Nemo Money has over 1 million (1M+) downloads with a high rating of 4.6 stars from thousands of reviews. Join Nemo and trade with 0% commission.Nemo Money has over 1 million (1M+) downloads with a high rating of 4.6 stars from thousands of reviews. Join Nemo and trade with 0% commission.Nemo Money has over 1 million (1M+) downloads with a high rating of 4.6 stars from thousands of reviews. Join Nemo and trade with 0% commission.Nemo Money has over 1 million (1M+) downloads with a high rating of 4.6 stars from thousands of reviews. Join Nemo and trade with 0% commission.
Ventas, Inc.

Ventas, Inc.

Ventas, Inc. (VTR) is a large US real estate investment trust (REIT) focused on healthcare-related properties, including senior housing, medical office buildings, hospitals and life-science facilities. With a market capitalisation of about $31.9bn, Ventas aims to generate rental income from long-term leases and specialised property operations. Key attractions for investors include exposure to demographic tailwinds in ageing populations and a diversified property mix that can smooth cash flows across care settings. Important risks include sensitivity to interest rates, leverage and the credit and operational health of healthcare operators and tenants; regulatory and reimbursement changes can also affect cash flow. Ventas has a history of distributing dividends, but dividend levels are not guaranteed and can change. This summary is for educational purposes only and is not personalised investment advice โ€” investors should consider their risk tolerance, tax situation and time horizon, and consult a financial adviser before investing.

Why It's Moving

Ventas, Inc.

Ventas Draws Bullish Analyst Firepower as Director Boosts Stake Amid Steady Gains.

Ventas, a leading healthcare REIT, is riding fresh Buy ratings from BMO Capital and Goldman Sachs, signaling strong confidence in its senior housing and outpatient portfolio resilience. A director's recent dividend-equivalent stock unit accrual further underscores internal alignment with shareholder interests, as shares hover near $77.
Sentiment:
๐ŸƒBullish
  • BMO Capital reiterated Buy while Goldman Sachs initiated coverage with Buy on January 19, bolstering the bullish Street view on Ventas' earnings growth to $6.9B revenue by 2028.
  • Director Maurice S. Smith added 57.483 cash deferral and 68.063 equity units on January 15 at $76.92/share, lifting his holdings to over 28,000 units and highlighting dividend strength.
  • Healthcare REIT outperforms with 10.9% three-month gain versus sector's 1.3% drop, fueled by $4.1B liquidity and improved net debt to EBITDA of 5.3X.

When is the next earnings date for Ventas, Inc. (VTR)?

Ventas, Inc. (VTR) is scheduled to report its next earnings on February 5, 2026, after market close, covering the fourth quarter of 2025 ending December 2025. The earnings call is set for the following day. This date aligns with consensus estimates from multiple analyst sources based on the company's historical reporting patterns.

Stock Performance Snapshot

Buy

Analyst Rating

Analysts recommend buying Ventas, Inc. stock with a target price of $84.94, indicating growth potential.

Above Average

Financial Health

Ventas, Inc. is generating strong revenue and cash flow, indicating solid financial performance.

Average

Dividend

Ventas, Inc.'s dividend yield of 2.46% provides a moderate return for dividend-seeking investors. If you invested $1000, you would be paid $24.60 a year in dividends (based on the last 12 months).

Source: Analyst sentiment is provided by Refinitiv Ltd, a global leader in financial market data with over 40k business clients. Refinitiv Ltd is an independent third party to Nemo. This is not advice.

Baskets Featuring VTR

Real Estate

Real Estate

Is it sunset or sunrise for real estate stocks? This carefully selected group of property investments, handpicked by our professional analysts, offers exposure to everything from data centers to residential properties and commercial real estate trusts.

Published: May 29, 2025

Explore Basket
Stagflation Standouts

Stagflation Standouts

This collection features stocks and assets carefully selected by professional analysts to potentially outperform during stagflation periods. These defensive investments have already shown strength while the broader market struggles, making them worth consideration for economic uncertainty ahead.

Published: May 19, 2025

Explore Basket

Why Youโ€™ll Want to Watch This Stock

๐Ÿ“ˆ

Demographic tailwinds

Ageing populations can support demand for senior housing and medical services, which may underpin long-term occupancy โ€” though local dynamics and regulations can affect outcomes.

๐ŸŒ

Property diversification

A mix of senior housing, medical office and life-science assets can smooth revenue streams across cycles, yet different sub-sectors carry distinct operational and market risks.

โšก

Rate & credit sensitivity

REIT valuations and dividend capacity are sensitive to interest-rate moves and tenant creditworthiness, so leverage and operator health are important to monitor.

Why invest with Nemo?

Nemo Logo Fade
๐Ÿ†“

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

๐Ÿ”’

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

๐Ÿ’ฐ

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

AGNC

AGNC Investment Corp.

AGNC Investment is a real estate investment trust that invests in mortgage-backed securities.

ADC

Agree Realty Corp

Invests in, develop, and manage net-leased properties.

AKR

Acadia Realty Trust

Real estate investment trust (REIT) that invests in retail and mixed-use properties in the US.

Frequently asked questions